Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 14, 2002 - Issue 4
30
Views
11
CrossRef citations to date
0
Altmetric
Research Article

AMBIENT PM 10 EXTRACTS INHIBIT PHAGOCYTOSIS OF DEFINED INERT MODEL PARTICLES BY ALVEOLAR MACROPHAGES

, &
Pages 369-385 | Published online: 01 Oct 2008
 

Abstract

We used inert melamin particles that are very well defined in size (diameters: 0.5, 1.9, 6.8 µm) to study the effects of ambient particles of <10 µm (PM 10) on phagocytosis. Dose-response functions were found between the amount of added melamin particle mass and the toxicity. Fine particles (0.5 µm) were more toxic at low and medium amounts of mass per cell added than the larger particles (1.9, 6.8 µm). However, with regard to particle numbers applied per cell, toxicity is reversed, with the largest particles being the most toxic. In the whole dose range tested, the melamin particles used did not stimulate cells to produce oxidative radicals or tumor necrosis factor-α (TNFα) . Flow cytometric analyses visualized the time-dependent melamin particle uptake, which was inhibited by polyinosinic acid (Poly-I), suggesting that phagocytosis is mediated by scavenger-type receptors. Cells exposed to an aqueous PM 10 extract, which also had a dose-dependent toxic potential, were stimulated to produce oxidative radicals, measured as NO 2 -, and TNFα. Combined exposures with the PM 10 extract followed by the inert melamin particles show that the PM 10 extract inhibits inert particle uptake by alveolar macrophages. It is proposed that ambient PM 10, besides being toxic for alveolar macrophages, stimulates them to produce oxidative radicals and the proinflammotry cytokine TNFα. Moreover, it inhibits their particle uptake potential. Thus PM 10 appears to promote inflammation and reduce defense.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.